Clariane SE (FRA:KO2) Valuation Rank


FRA:KO2 Clariane SE FRA:KO2
59 GF Score
Price €4.18
GF Value €2.47
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Clariane SE Valuation Rank Related Terms

FRA:KO2
59GF Score
Clariane SE FRA:KO2
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clariane SE (FRA:KO2) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.18 is trading 69.1% above its estimated GF Value™ of €2.47. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for FRA:KO2:

  • Valuation Rank:
  • GF Value™: €2.47 vs. price of €4.18 (69.1% above fair value)
  • GF Score™: 59/100 with 9 warning signs

No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
59GF Score

Get the complete analysis for FRA:KO2

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.18
Price
€2.47
GF Value